Inhibition of mouse trypsin isoforms by SPINK1 and effect of human pancreatitis-associated mutations
Pancreatology · 2023
DOI: 10.1016/j.pan.2023.04.043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2023. Verfasst von Nataly C Morales Granda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; Doctoral School of Molecular, Cell …. Hauptthemen laut MEDLINE: Trypsin Inhibitor, Kazal Pancreatic, Pancreatitis, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Serine protease inhibitor Kazal type 1 (SPINK1) is a trypsin-selective inhibitor protein secreted by the exocrine pancreas. Loss-of-function SPINK1 mutations predispose to chronic pancreatitis through either reduced expression, secretion, or impaired trypsin inhibition. In this study, we aimed to characterize the inhibitory activity of mouse SPINK1 against cationic (T7) and anionic (T8, T9, T20) mouse trypsin isoforms. Kinetic measurements with a peptide substrate, and digestion experiments with β-casein indicated that the catalytic activity of all mouse trypsins is comparable. Human SPINK1 and its mouse ortholog inhibited mouse trypsins with comparable efficiency (KD range 0.7-2.2 pM), with the sole exception of T7 trypsin, which was inhibited less effectively by the human inhibitor (KD 21.9 pM). Characterization of four chronic pancreatitis-associated human SPINK1 mutations in the context of the mouse inhibitor revealed that the reactive-loop mutations R42N (human K41N) and I43M (human I42M) impaired SPINK1 binding to trypsin (KD 60 nM and 47.5 pM, respectively), whereas mutations D35S (human N34S) and A56S (human P55S) had no impact on trypsin inhibition. Our results confirmed that high-affinity trypsin inhibition by SPINK1 is conserved in the mouse, and the functional consequences of human pancreatitis-associated SPINK1 mutations can be replicated in the mouse inhibitor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; Doctoral School of Molecular, Cell and Immune Biology, University of Debrecen, Debrecen, Hungary.
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address: andrasszabo@med.unideb.hu.
Zitieren
APA
Morales Granda, N. C., Toldi, V., Miczi, M., Lassoued, M., & Szabó, A. (2023). Inhibition of mouse trypsin isoforms by SPINK1 and effect of human pancreatitis-associated mutations. Pancreatology. https://doi.org/10.1016/j.pan.2023.04.043
Vancouver
Morales Granda NC, Toldi V, Miczi M, Lassoued M, Szabó A. Inhibition of mouse trypsin isoforms by SPINK1 and effect of human pancreatitis-associated mutations. Pancreatology. 2023. doi:10.1016/j.pan.2023.04.043
BibTeX
@article{MoralesGranda2023,
author = {Morales Granda, Nataly C and Toldi, Vanda and Miczi, Márió and Lassoued, Meriam and Szabó, András},
title = {Inhibition of mouse trypsin isoforms by SPINK1 and effect of human pancreatitis-associated mutations},
journal = {Pancreatology},
year = {2023},
doi = {10.1016/j.pan.2023.04.043}
}
EUVIMED